4//SEC Filing
Fyfe Gwen A. 4
Accession 0001562180-17-003341
CIK 0001100412other
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 4:28 PM ET
Size
11.8 KB
Accession
0001562180-17-003341
Insider Transaction Report
Form 4
Fyfe Gwen A.
Director
Transactions
- Exercise/Conversion
Common Stock
2017-10-27$10.47/sh+5,000$52,350→ 10,000 total - Award
Stock Option (Right to Buy)
2017-10-26+25,000→ 25,000 totalExercise: $10.47From: 2018-10-26Exp: 2027-10-26→ Common Stock (25,000 underlying) - Award
Restricted Stock Units
2017-10-26+5,000→ 5,000 totalExercise: $0.00From: 2018-10-26→ Common Stock (5,000 underlying) - Exercise/Conversion
Restricted Stock Units
2017-10-27−5,000→ 0 totalExercise: $0.00From: 2017-10-27→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by the Issuer on October 27, 2016 as a result of the vesting of all such RSUs.
- [F2]RSUs awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The units vest and will be settled in stock on October 26, 2018, subject to continued service on Array's board of directors.
- [F3]RSUs awarded to the reporting person on October 27, 2016 for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The units vested and were settled in stock on October 27, 2017.
Documents
Issuer
ARRAY BIOPHARMA INC
CIK 0001100412
Entity typeother
Related Parties
1- filerCIK 0001506217
Filing Metadata
- Form type
- 4
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 4:28 PM ET
- Size
- 11.8 KB